TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/12/2025
Voltar para busca
Dado oficial do USPTO
I-MAB BIOPHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
04/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
17/07/2019
Data de registro
20/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/09/2022
Última transação
04/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
21/12/2020
Primeiro uso no comércio
21/12/2020
Código do desenho
3
Tipo de titular
03
Localização do titular
ROCKVILLE, MD
Examinador
RINGLE,JAMES W
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a blue and green stylized ring having a blue and dark blue left portion and a green and light green right portion. To the right of the ring is the word "I-MAB" written in dark blue upper case letters with a fading green arched cross-stroke extending from the left leg of the letter "A" through its center and extending through the center of the letter "B." Below the word "I-MAB" is the word "BIOPHARMA" written in dark blue upper case letters, and below "BIOPHARMA" are four Chinese characters written in green. The color white appearing in the mark represents transparent space and is not a part of the mark.
Titulares e representantes
Titulares
I-MAB BIOPHARMA US LIMITED
I-MAB BIOPHARMA CO., LTD
I-MAB
Representantes
Jacqueline Lesser Ice Miller LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders
Classe 42
Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/04/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
25/12/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17/05/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
20/09/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/08/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/08/2022
IUAF
USE AMENDMENT FILED
27/07/2022
EISU
TEAS STATEMENT OF USE RECEIVED
27/07/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2021
PUBO
PUBLISHED FOR OPPOSITION
07/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/10/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2021
GNRT
NON-FINAL ACTION E-MAILED
01/07/2021
CNRT
NON-FINAL ACTION WRITTEN
01/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/06/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/06/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
13/04/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
13/10/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/04/2020
GNSL
LETTER OF SUSPENSION E-MAILED
09/04/2020
CNSL
SUSPENSION LETTER WRITTEN
09/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/10/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/10/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2019
GNRT
NON-FINAL ACTION E-MAILED
12/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
DOCK
ASSIGNED TO EXAMINER
10/09/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
26/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/07/2019
NWAP
NEW APPLICATION ENTERED
20/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace I-MAB BIOPHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.